Literature DB >> 25755913

Recurrent papillary thyroid carcinoma with pleural metastasis diagnosed by effusion cytology: a report of cases with clinicopathologic correlation.

Reid I Sakamoto1, Lauren C Sumida1, Christopher A K Lum1, Pamela S Tauchi-Nishi1.   

Abstract

Papillary thyroid carcinoma (PTC) is typically an indolent disease characterized by slow growth and a favorable prognosis. In rare instances, this disease may metastasize to the pleura and manifest as a malignant pleural effusion. We report 3 female patients of Japanese/Okinawan ancestry with a history of PTC who presented with hydrothorax. Cytologic examination in conjunction with immunohistochemical staining enabled a definitive diagnosis of metastatic PTC. Molecular analysis of the mitogen activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways demonstrated the presence of the v-raf murine sarcoma viral oncogene homolog B (BRAF)(V600E) mutation in 2 of our 3 patients, with the absence of any other clinically significant mutations in all cases. Further investigation is necessary to elucidate the molecular and environmental mechanisms involved in this aggressive manifestation of PTC.

Entities:  

Keywords:  BRAFV600E mutation; effusion cytology; metastatic papillary thyroid carcinoma; pleural metastasis

Mesh:

Year:  2015        PMID: 25755913      PMCID: PMC4338567     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  24 in total

1.  [Pleural metastasis as presenting form of papillary thyroid microcarcinoma: an exceptional case].

Authors:  C Pérez Vega; A Lecube Torelló; J Narváez García; J Vilaseca Momplet
Journal:  Rev Clin Esp       Date:  2003-04       Impact factor: 1.556

2.  Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study.

Authors:  Y Mizukami; T Michigishi; A Nonomura; T Hashimoto; S Terahata; M Noguchi; K Hisada; F Matsubara
Journal:  Hum Pathol       Date:  1990-03       Impact factor: 3.466

Review 3.  BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications.

Authors:  Kam-Tsun Tang; Chen-Hsen Lee
Journal:  J Chin Med Assoc       Date:  2010-03       Impact factor: 2.743

4.  Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population.

Authors:  Kyung Hee Kim; Dong Wook Kang; Seong Ho Kim; In Ock Seong; Dae Young Kang
Journal:  Yonsei Med J       Date:  2004-10-31       Impact factor: 2.759

5.  BRAF mutations in papillary carcinomas of the thyroid.

Authors:  Toshihiko Fukushima; Shinichi Suzuki; Miyuki Mashiko; Tohru Ohtake; Yoshiyuki Endo; Yuji Takebayashi; Koji Sekikawa; Koichi Hagiwara; Seiichi Takenoshita
Journal:  Oncogene       Date:  2003-09-25       Impact factor: 9.867

6.  Fine needle aspiration of follicular variant of papillary thyroid carcinoma presenting with pleural effusion: a case report.

Authors:  Neelaiah Siddaraju; Vinod Kumar Viswanathan; Vinod Kumar Saka; Debdatta Basu; Chandrakumar Shanmugham
Journal:  Acta Cytol       Date:  2007 Nov-Dec       Impact factor: 2.319

Review 7.  Cardiac tamponade as the initial presentation of papillary thyroid carcinoma.

Authors:  C S Kovacs; G K Nguyen; J C Mullen; P M Crockford
Journal:  Can J Cardiol       Date:  1994-03       Impact factor: 5.223

8.  [Extensive pulmonary tumor embolisms of anaplastic thyroid gland carcinoma as a rare cause of hemorrhagic pleural effusion in an 88-year-old patient].

Authors:  H Köppl; E Scheer; E W Herbst
Journal:  Pneumologie       Date:  1993-10

9.  Volcanoes and carcinoma of the thyroid: a possible association.

Authors:  T M Kung; W L Ng; J B Gibson
Journal:  Arch Environ Health       Date:  1981 Sep-Oct

Review 10.  Aggressive variants of follicular cell-derived thyroid carcinomas: a cytopathologist's perspective.

Authors:  Ricardo R Lastra; Virginia A LiVolsi; Zubair W Baloch
Journal:  Cancer Cytopathol       Date:  2014-03-24       Impact factor: 5.284

View more
  1 in total

1.  Pleural effusion as a novel prognostic factor in metastatic thyroid carcinoma.

Authors:  David T Broome; Gauri B Gadre; Ehsan Fayazzadeh; James F Bena; Christian Nasr
Journal:  Endocr Connect       Date:  2020-08       Impact factor: 3.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.